Back to Search
Start Over
S100A4 is an independent prognostic factor for patients with lung cancer: a meta-analysis
- Source :
- Genetic testing and molecular biomarkers. 18(5)
- Publication Year :
- 2014
-
Abstract
- Objective: To evaluate the association of S100A4 levels with the prognosis of lung cancer (LC). Methods: The RevMan 5.0 software was utilized to perform literature retrieval, data collection, and statistical analysis according to its guidelines. Literature-based searching was guided to gather data, and the fixed-effect model was used to pool the hazard ratio (HR) in this study. Results: A total of 10 eligible studies that included 1364 LC patients were analyzed. About 72.6% of patients had positive expression of S100A4 according to the criteria defined by the authors. The HR of positive expression for overall survival (OS) was 1.30 times of that of negative expression in LC patients (HR=1.30, 95% confidence interval: 1.04 to 1.61, p=0.02). Conclusion: Patients with positive expression of S100A4 appear to have a poorer OS compared with those with negative expression of S100A4.
- Subjects :
- Oncology
medicine.medical_specialty
Prognostic factor
Lung Neoplasms
business.industry
Hazard ratio
S100 Proteins
General Medicine
Bioinformatics
medicine.disease
Prognosis
Survival Analysis
Confidence interval
Meta-analysis
Internal medicine
Overall survival
Biomarkers, Tumor
Medicine
Humans
Statistical analysis
S100 Calcium-Binding Protein A4
business
Lung cancer
Genetics (clinical)
Subjects
Details
- ISSN :
- 19450257
- Volume :
- 18
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Genetic testing and molecular biomarkers
- Accession number :
- edsair.doi.dedup.....d705cd598790e4fa33a116b594cb9f0f